What Is Quality by Design and Why It Matters in PharmaUntitledA Science-Based Route to Consistent Medicines
Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical product and process development that builds quality into a medicine from the design stage rather than testing it in at the end. Quality by Design training in the Maldives gives pharmaceutical scientists, quality and regulatory professionals the practical tools to apply this approach with confidence. The programme is grounded in the ICH guidelines: Q8(R2) on Pharmaceutical Development, Q9 on Quality Risk Management, Q10 on the Pharmaceutical Quality System and Q11 on drug substances. It shows how QbD is increasingly expected by regulators such as the FDA and EMA as the foundation of modern pharmaceutical submissions. Over one focused day you learn the structured QbD toolkit: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment with Ishikawa diagrams and FMEA, Design of Experiments (DoE), the design space, Process Analytical Technology (PAT) and the Control Strategy. For professionals in the Maldives' growing medicine import, distribution and healthcare sector, these are skills you can apply straight away to product understanding, supplier quality and regulatory readiness. Delivered by Invensis Learning in live virtual, classroom and corporate formats, the training turns QbD theory into workplace capability. Start building quality into your products from day one.










